
GSK vs NVO
$GSK vs $NVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs NVO: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+11.2%). Split-adjusted daily closes.
- ·Both trends are mixed, above one moving average and below the other, which is how a stock looks while it changes direction.
- ·Neither kept up with the market over the past year: GSK +6.1% and NVO -14.2%, against the S&P 500 at +11.2%.
- ·The last month has flipped the order: NVO leads over the month (+7.1% against +1.8%) even though GSK leads over the year.
- ·GSK sits closer to its support, 0.6% above it at $49.63, while NVO is 3.7% above its own at $39.64.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs NVO: the quick read
- ·NVO is the larger company by market cap ($141.03B vs $101.97B).
- ·NVO has been more active on our scanner (108 vs 69 alerts in 30 days).
- ·GSK has the smaller float (2.00B vs 4.41B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 108 and 69 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 38% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
Objective differences only. Not investment advice.
Watching GSK or NVO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and NVO on TheDesperateTrader.
- Is GSK or NVO the better stock?
- "Better" depends on your goal, and these two are not alike. NVO is the larger company by market cap ($141.03B vs $101.97B). NVO has been more active on our scanner (108 vs 69 alerts in 30 days). GSK has the smaller float (2.00B vs 4.41B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and NVO?
- The differences that matter: they are similar in size ($101.97B vs $141.03B); they trade at very different share prices ($49.95 vs $41.17); GSK sits at 26% of its 52-week range against 21% for NVO; our scanner flagged GSK 69 times in the last 30 days against 108 for NVO. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and NVO is more active right now?
- Right now GSK is at about 0.6x its normal volume and NVO is at about 1.5x, so NVO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or NVO in the stronger trend?
- GSK is above its 50-day average of $49.31 and below its 200-day average of $52.40; NVO is above its 50-day average of $39.99 and below its 200-day average of $43.09. GSK leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or NVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GSK and NVO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.